These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use. Ho M; Yang D; Wyle FA; Mulligan ME Clin Infect Dis; 1996 Dec; 23 Suppl 1():S102-6. PubMed ID: 8953115 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a nosocomial Clostridium difficile outbreak by using plasmid profile typing and clindamycin susceptibility testing. Clabots CR; Peterson LR; Gerding DN J Infect Dis; 1988 Oct; 158(4):731-6. PubMed ID: 2844914 [TBL] [Abstract][Full Text] [Related]
27. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital. Kaneria MV; Paul S J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. von Müller L; Mock M; Halfmann A; Stahlmann J; Simon A; Herrmann M Int J Med Microbiol; 2015 Oct; 305(7):807-13. PubMed ID: 26341328 [TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes. Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich. Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433 [TBL] [Abstract][Full Text] [Related]
31. [Diarrhea associated with Clostridium difficile. One-year retrospective study at a tertiary hospital]. Barreiro PM; Pintor E; Rosario Burón M; Díaz B; Valverde J; de la Torre F Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):359-63. PubMed ID: 9835150 [TBL] [Abstract][Full Text] [Related]
32. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis. Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595 [TBL] [Abstract][Full Text] [Related]
33. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. Kim J; Kang JO; Pai H; Choi TY Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765 [TBL] [Abstract][Full Text] [Related]
34. The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Langley JM; LeBlanc JC; Hanakowski M; Goloubeva O Infect Control Hosp Epidemiol; 2002 Nov; 23(11):660-4. PubMed ID: 12452293 [TBL] [Abstract][Full Text] [Related]
35. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China. Wang R; Suo L; Chen HX; Song LJ; Shen YY; Luo YP Int J Infect Dis; 2018 Feb; 67():86-91. PubMed ID: 28736259 [TBL] [Abstract][Full Text] [Related]
36. [Nosocomial diarrhea outbreak due to Clostridium difficile in a vascular surgery department]. Pazos R; Isusi A; Fernández R; Barbeito L; Bravo A; Cantón I; Gayoso P; Lebrato R Enferm Infecc Microbiol Clin; 2003 May; 21(5):237-41. PubMed ID: 12732113 [TBL] [Abstract][Full Text] [Related]
37. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China. Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Barbut F; Corthier G; Charpak Y; Cerf M; Monteil H; Fosse T; Trévoux A; De Barbeyrac B; Boussougant Y; Tigaud S; Tytgat F; Sédallian A; Duborgel S; Collignon A; Le Guern ME; Bernasconi P; Petit JC Arch Intern Med; 1996 Jul; 156(13):1449-54. PubMed ID: 8678714 [TBL] [Abstract][Full Text] [Related]
39. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. Gordon D; Young LR; Reddy S; Bergman C; Young JD J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410 [TBL] [Abstract][Full Text] [Related]
40. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Gerding DN Clin Infect Dis; 2004 Mar; 38(5):646-8. PubMed ID: 14986247 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]